EMED Electromedical Technologies, Inc
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1715819 · Fiscal year ends 12/31
Financial factors as of 2024-09-30 (2024Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-35.1%
TTM net income YoY46.3%
TTM EPS YoY—
Revenue 3-yr CAGR2.7%
Net income 3-yr CAGR—
Margins
Gross margin75.1%
Operating margin-109.6%
Net margin-182.0%
FCF margin—
EBITDA margin-109.6%
Returns
ROE—
ROA-236.0%
ROIC (approx.)—
Asset turnover1.30x
Leverage & solvency
Liabilities / assets804.1%
Debt / equity—
Current ratio0.07x
Interest coverage-4.38x
Cash quality & payout
Operating cash flow / net income0.08x
Accruals ratio-217.6%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2024Q32024-09-30 | 2024Q22024-06-30 | 2024Q12024-03-31 | 2023Q4*2023-12-31 | 2023Q32023-09-30 | 2023Q22023-06-30 | 2023Q12023-03-31 | 2022Q4*2022-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $42,526 | $237,645 | $290,244 | $351,595 | $323,613 | $294,954 | $378,646 | $423,148 |
| Cost of revenue | $11,881 | $64,390 | $72,857 | $80,651 | $72,437 | $62,519 | $87,696 | $90,219 |
| Gross profit | $30,645 | $173,255 | $217,387 | $270,944 | $251,176 | $232,435 | $290,950 | $332,929 |
| SG&A expense | $411,683 | $425,100 | $372,263 | $493,915 | $490,205 | $573,838 | $1.55M | $590,261 |
| Operating income | -$381,038 | -$251,845 | -$154,876 | -$222,971 | -$239,029 | -$341,403 | -$1.26M | -$257,332 |
| Interest expense | $54,914 | $58,301 | $59,320 | $58,346 | $162,121 | $284,487 | $388,201 | $280,655 |
| Net income | -$724,643 | $231,236 | -$836,274 | -$348,657 | -$376,720 | -$1.46M | -$456,063 | -$830,087 |
| EBITDA | -$381,038 | -$251,845 | -$154,876 | -$222,971 | -$239,029 | -$341,403 | -$1.26M | -$251,863 |
| EPS (basic) | 0.00 | 0.00 | -0.00 | — | 0.00 | 0.00 | -0.00 | — |
| EPS (diluted) | — | 0.00 | -0.00 | — | 0.00 | 0.00 | -0.00 | — |
| Weighted avg. shares (diluted) | — | 1.94B | 464.82M | — | 466.22M | 335.50M | 240.57M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $34,809 | $116,931 | $78,843 | $87,704 | $138,477 | $416,256 | $1.24M | $368,425 |
| Receivables | $7,251 | $4,338 | $3,501 | $4,399 | $9,200 | $25,788 | $5,826 | $9,444 |
| Inventory | $24,256 | $31,681 | $46,561 | $68,517 | $131,310 | $113,151 | $159,704 | $62,061 |
| Current assets | $305,361 | $389,224 | $419,375 | $449,185 | $543,004 | $881,996 | $1.57M | $647,802 |
| PP&E, net | $149,705 | $149,705 | $149,705 | $149,705 | $149,705 | $149,705 | — | $705,469 |
| Total assets | $568,813 | $664,959 | $707,022 | $748,383 | $853,403 | $1.03M | $1.57M | $1.35M |
| Current liabilities | $4.36M | $3.83M | $4.15M | $3.36M | $3.09M | $3.15M | $2.44M | $2.92M |
| Long-term debt | — | — | — | $150,000 | — | — | — | $671,525 |
| Total debt | — | — | — | $150,000 | — | — | — | $671,525 |
| Total liabilities | $4.57M | $4.06M | $4.40M | $3.62M | $3.37M | $3.31M | $2.60M | $3.57M |
| Shareholders' equity | -$4.00M | -$3.40M | -$3.69M | -$2.87M | -$2.52M | -$2.28M | -$1.03M | -$2.22M |
| Net debt | — | — | — | $62,296 | — | — | — | $303,100 |
| Shares outstanding | 725.35M | 566.11M | 486.48M | 463.29M | 471.50M | 432.49M | 296.89M | 189.78M |
| Cash flow statement | ||||||||
| Operating cash flow | -$30,829 | $108,927 | -$158,361 | -$50,948 | -$277,779 | -$635,930 | -$452,736 | -$33,099 |
| Capital expenditure | — | — | — | $0 | $0 | — | — | — |
| Free cash flow | — | — | — | -$50,948 | -$277,779 | — | — | — |
| Investing cash flow | — | — | — | $0 | $0 | -$149,705 | $1.89M | — |
| Financing cash flow | -$51,293 | -$70,839 | $149,500 | $175 | $0 | -$33,136 | -$575,250 | -$57,391 |
| Depreciation & amortization | $0 | $0 | $0 | $0 | $0 | $0 | $4,557 | $5,469 |
| Stock-based compensation | — | — | — | $0 | $0 | $0 | $715,000 | $25,000 |
Free plan shows the latest 8 periods; Pro shows all 23 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.